Journal of Sports Science and Medicine

Table 7. Total Phopshoprotein levels of insulin signaling pathway intermediate before and after SizeOn maximum performance supplementation and resistance training. Values are means (±SD).

Variable	Group	Day 0	Day 43	Group (p ≤ .05)	Test (p ≤ .05)	Group x Test (p ≤ .05)
Total IRS-1 (ng·mg^–1)	SIZE	.657 (.157)	.807 (.285) *	.073	.041	.154
Total IRS-1 (ng·mg^–1)	PCC	.610 (.127)	.767 (.149) *	.073	.041	.154
Total Akt (ng·mg^–1)	SIZE	.365 (.160)	.498 (.111) *	.442	.011	.142
Total Akt (ng·mg^–1)	PCC	.371 (.120)	.505 (.141) *	.442	.011	.142
Total p70S6K (ng·mg^–1)	SIZE	.014 (.004)	.019 (.011)	.136	.403	.467
Total p70S6K (ng·mg^–1)	PCC	.015 (.005)	.013 (.003)	.136	.403	.467
Total 4EBP-1 (ng·mg^–1)	SIZE	.076 (.039)	.096 (.042)	.431	.276	.779
Total 4EBP-1 (ng·mg^–1)	PCC	.091 (.057)	.102 (.071)	.431	.276	.779

Muscle phosphoprotein levels for the PCC (n = 12) and SIZE (n = 12) groups.

* denotes a significant increase at Day 43. Resistance training increased total IRS-1 (p = 0.041) and Akt (p = 0.011) protein content.